Scott Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$731K Buy
2,878
+11
+0.4% +$2.56K 0.11% 41
2026
Q1
$684K Buy
2,867
+9
+0.3% +$2.1K 0.14% 38
2025
Q4
$591K Buy
2,858
+6
+0.2% +$1.19K 0.13% 38
2025
Q3
$541K Buy
2,852
+4
+0.1% +$685 0.12% 37
2025
Q2
$445K Sell
2,848
-7
-0.2% -$1.08K 0.12% 36
2025
Q1
$473K Sell
2,855
-88
-3% -$13.8K 0.14% 35
2024
Q4
$425K Sell
2,943
-619
-17% -$95.9K 0.12% 36
2024
Q3
$577K Buy
3,562
+2
+0.1% +$319 0.16% 37
2024
Q2
$524K Buy
3,560
+52
+1% +$7.73K 0.15% 35
2024
Q1
$534K Buy
3,508
+54
+2% +$8.6K 0.16% 33
2023
Q4
$541K Buy
3,454
+27
+0.8% +$4.14K 0.18% 31
2023
Q3
$540K Buy
3,427
+41
+1% +$6.76K 0.22% 30
2023
Q2
$560K Buy
3,386
+80
+2% +$12.9K 0.24% 31
2023
Q1
$512K Buy
3,306
+74
+2% +$11.9K 0.25% 30
2022
Q4
$571K Sell
3,232
-28
-0.9% -$4.83K 0.32% 26
2022
Q3
$533K Buy
3,260
+92
+3% +$15.6K 0.36% 24
2022
Q2
$562K Sell
3,168
-14
-0.4% -$2.49K 0.38% 25
2022
Q1
$564K Buy
3,182
+25
+0.8% +$4.25K 0.33% 29
2021
Q4
$540K Buy
+3,157
New +$517K 0.33% 23

Other funds holding JNJ

Scott Capital Advisors's JNJ Position: Q2 2026 in Review

Scott Capital Advisors increased its Johnson & Johnson (JNJ) stake by 0.38% in Q2 2026, buying an estimated $2.56K and bringing the position to 2,878 shares worth $731K. The position accounts for 0.11% of the portfolio, ranked #41.

Scott Capital Advisors first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Scott Capital Advisors held 2,878 shares of Johnson & Johnson worth $731K as of Q2 2026.
  • Scott Capital Advisors bought 11 Johnson & Johnson shares in Q2 2026, an estimated $2.56K.
  • Johnson & Johnson made up 0.11% of Scott Capital Advisors's portfolio in Q2 2026, its #41 holding.
  • Scott Capital Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Scott Capital Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.